1302 logo

LifeTech Scientific Corporation Stock Price

SEHK:1302 Community·HK$7.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1302 Share Price Performance

HK$1.62
0.04 (2.53%)
HK$1.62
0.04 (2.53%)
Price HK$1.62

1302 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

2 Risks
1 Reward

LifeTech Scientific Corporation Key Details

CN¥1.4b

Revenue

CN¥350.7m

Cost of Revenue

CN¥1.0b

Gross Profit

CN¥871.3m

Other Expenses

CN¥147.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.032
74.40%
10.79%
0%
View Full Analysis

About 1302

Founded
1999
Employees
1245
CEO
Yuehui Xie
WebsiteView website
www.lifetechmed.com

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

Recent 1302 News & Updates

Recent updates

No updates